|
MARKETWATCH
The Educational Potential Of Direct-To-Consumer Prescription Drug Advertising
Kimberly A. Kaphingst and
William DeJong
Food and Drug Administration (FDA) regulations for direct-to-consumer (DTC) prescription drug advertising allow broadcast advertisements with incomplete risk information if the ads refer consumers to physicians, pharmacists, and supplemental information sources. New research reveals several problems with both television advertisements and supplemental text materials that might compromise their ability to meet the FDAs requirement for "fair balance" in the presentation of risks and benefits. In response, we make several recommendations to improve the educational quality of DTC advertising, which can be implemented through either voluntary agreements or revised FDA regulations.

What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. A. Abel, H. J. Burstein, N. D. Hevelone, and J. C. Weeks
Cancer-Related Direct-to-Consumer Advertising: Awareness, Perceptions, and Reported Impact Among Patients Undergoing Active Cancer Treatment
J. Clin. Oncol.,
September 1, 2009;
27(25):
4182 - 4187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Hollon
Direct-to-Consumer Advertising: A Haphazard Approach to Health Promotion
JAMA,
April 27, 2005;
293(16):
2030 - 2033.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Cunningham and J. Kirby
Children's Health Coverage: A Quarter-Century Of Change
Health Aff.,
September 1, 2004;
23(5):
27 - 38.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Comments:
Read all Comments
- Brief Summaries Formats for Direct-to-Consumer Prescription Drug Advertising
- Sujit S. Sansgiry, et al.
- Health Affairs, 25 Aug 2004
[Full text]
|